Table 2.
The results of the univariate Cox regression analysis.
| Variable | PFS | OS | ||
|---|---|---|---|---|
| HR (95%CI) | P | HR (95%CI) | P | |
| Gender | 1.993 (1.199-3.311) | 0.029* | 6.79 (2.118-21.76) | 0.033* |
| PD-L1 1% | 1.034 (0.625-1.709) | 0.896 | 1.41 (0.447-4.445) | 0.550 |
| PD-L1 50% | 0.610 (0.322-1.153) | 0.075 | 0.327 (0.077-1.387) | 0.045* |
| TNM | 0.460 (0.280-0.756) | 0.002* | 0.585 (0.188-1.824) | 0.353 |
| Pathology | 1.765 (1.004-3.102) | 0.025* | 0.950 (0.262-3.454) | 0.939 |
| Smoke | 0.188 (0.114-0.307) | <0.001* | 0.127 (0.056-0.285) | 0.001* |
| Treatment | 2.526 (1.503-4.245) | 0.001* | 2.619 (0.799-8.589) | 0.087 |
| Metastasis | 0.391 (0.204-0.751) | <0.001* | 0.326 (0.077-1.384) | 0.044* |
| Ki-67 | 0.265 (0.156-0.449) | 0.001* | 0.470 (0.137-1.618) | 0.317 |
| LN | 0.310 (0.188-0.511) | <0.001* | 0.189 (0.084-0.426) | <0.001* |
| SUVmax | 5.428 (3.196-9.222) | <0.001* | 4.252 (1.243-14.54) | 0.021* |
| MTV | 2.706 (1.632-4.489) | 0.001* | 4.446 (1.403-14.09) | 0.014* |
| TLG (mL) | 4.938 (2.993-8.147) | <0.001* | 3.159 (0.903-11.06) | 0.007* |
| Rad-score | 8.178 (4.953-13.50) | <0.001* | 27.61 (7.883-96.72) | <0.001* |
LN, lymph node; SUVmax, standardized uptake value max; MTV, total metabolic tumor volume; TLG, total lesion glycolysis.
*P < 0.05.